Jul 06, 2016 7:05am EDT Immunovaccine Announces Positive Interim Phase 1 Data for DepoVax(TM)-Based Respiratory Syncytial Virus Vaccine Candidate
Jun 23, 2016 7:05am EDT Leidos Selects Immunovaccine's DepoVax(TM) Platform to Evaluate Its USAID-Backed Malaria Vaccine Research
Jun 02, 2016 7:05am EDT Immunovaccine Announces Preclinical Collaboration for DepoVax(TM)-Based Malaria Vaccine
May 05, 2016 7:05am EDT Immunovaccine Launches DPX-NEO Program to Develop Patient-Specific Neoepitope Immunotherapies
Apr 28, 2016 7:05am EDT Immunovaccine to Present at Bloom Burton & Co. Healthcare Investor Conference
Apr 20, 2016 7:05am EDT New Preclinical Study Shows Immunovaccine's DepoVax(TM)-Based Cancer Vaccine May Improve Efficacy of Checkpoint Inhibitors
Apr 15, 2016 7:05am EDT Immunovaccine Elects Medicago CEO Andy Sheldon as Board Chairman; Reports Results of the Annual General Meeting (AGM)
Apr 13, 2016 7:05am EDT Immunovaccine Names Frederic Ors Chief Executive Officer; Andy Sheldon, Medicago CEO, to Join Board of Directors
Apr 11, 2016 5:05pm EDT Immunovaccine to Present New Pre-Clinical Data at the 2016 AACR Annual Meeting